The short answer: Stage 3a and Stage 3b chronic kidney disease (CKD) are both considered stage 3 CKD, but they represent different levels of reduced kidney function. Stage 3a has an eGFR of 45–59 mL/min/1.73 m², while Stage 3b has an eGFR of 30–44. Stage 3b generally carries greater risk of complications and progression than Stage 3a, but your eGFR number alone does not determine your outlook. Albumin in the urine, the cause of CKD, blood pressure, diabetes, age, other health conditions, and the trend in kidney function all matter.
Stage 3a vs Stage 3b: What Is the Difference?
Stage 3a CKD means an eGFR of 45–59 mL/min/1.73 m².
Stage 3b CKD means an eGFR of 30–44 mL/min/1.73 m².
Both indicate reduced kidney function, but Stage 3b represents a greater reduction.
These ranges apply when reduced kidney function is persistent for at least 3 months or there is other evidence of chronic kidney damage. A single low eGFR does not automatically establish CKD because an acute illness or acute kidney injury (AKI) can temporarily reduce kidney function.
What Does eGFR Actually Mean?
eGFR, or estimated glomerular filtration rate, is an estimate of how well your kidneys filter blood.
It is usually calculated from blood creatinine along with other factors. Because it is an estimate rather than a direct measurement, the result can be affected by factors such as muscle mass, age, hydration, medications, and changes in health.
For example, an eGFR changing from 52 to 47 does not automatically mean that CKD has suddenly progressed. Small fluctuations can occur, and the result needs to be considered alongside previous measurements and the circumstances in which the test was performed.
Why Is Stage 3b Generally More Concerning?
As eGFR falls, the risk of CKD-related complications generally increases. This is why Stage 3b is considered a more advanced category than Stage 3a.
However, Stage 3b does not mean kidney failure is imminent.
Two people can both have an eGFR of 35 but have very different risks. One may have little or no albuminuria and stable kidney function, while another may have substantial albuminuria and a rapidly falling eGFR.
Current CKD classification therefore considers three things:
Cause + GFR category + albuminuria category.
Albuminuria is commonly assessed using the urine albumin-to-creatinine ratio (uACR):
- A1: less than 30 mg/g
- A2: 30–299 mg/g
- A3: 300 mg/g or higher
Higher albuminuria generally indicates greater kidney and cardiovascular risk.
Does Stage 3b Mean CKD Is Progressing?
Not necessarily.
A person can remain in Stage 3b for years, while another person’s kidney function may decline more quickly. The important question is often what the eGFR is doing over time.
A useful way to look at your results is:
Previous eGFR → current eGFR → size of change → time interval → clinical context
For example, a gradual change from 48 to 43 over several years is very different from a sudden fall from 48 to 30 over a few weeks.
A sudden decline may indicate AKI rather than ordinary CKD progression, particularly if there has been dehydration, infection, obstruction, medication-related kidney injury, or another acute problem.
This distinction matters because AKI can sometimes improve when its underlying cause is treated.
What Increases the Risk of CKD Progression?
Important factors include:
- Higher or increasing albuminuria
- A persistently declining eGFR
- Diabetes
- High blood pressure
- Certain kidney diseases
- Cardiovascular disease
- Previous episodes of AKI
- Some medications or exposures that can harm the kidneys
- Smoking and other cardiovascular risk factors
The exact cause of CKD is also important. Treating the underlying cause can change the course of disease.
What Symptoms Should You Expect?
Neither Stage 3a nor Stage 3b necessarily causes obvious symptoms.
Some people have fatigue, swelling, changes in urination, muscle cramps, itching, sleep problems, or other symptoms. But these symptoms are not specific to CKD and can have many other causes.
For example, fatigue may result from anemia, poor sleep, thyroid disease, medications, or other conditions—not simply from the eGFR number.
That is why symptoms should not be used alone to determine whether CKD is getting worse.
What Should You Monitor?
If you have Stage 3 CKD, your healthcare professional may monitor several factors rather than focusing only on creatinine and eGFR.
Depending on your situation, this can include:
- eGFR and creatinine
- Urine albumin-to-creatinine ratio (uACR)
- Blood pressure
- Potassium and other electrolytes
- Bicarbonate
- Hemoglobin
- Calcium and phosphorus
- Diabetes-related measures when applicable
- Medication use and doses
The frequency of testing should depend on your CKD category, albuminuria, rate of change, cause, and other health conditions.
What Can You Do to Protect Kidney Function?
There is no single treatment that applies to everyone with Stage 3 CKD. Management is based on the cause and individual risk.
Useful steps may include:
- Keep blood pressure under appropriate control.
- Manage diabetes if you have it.
- Have urine albumin checked rather than relying on eGFR alone.
- Review medications with your healthcare professional, particularly if kidney function changes.
- Avoid unnecessary use of potentially kidney-harming medicines such as NSAIDs unless your clinician advises otherwise.
- Follow an appropriate eating pattern rather than automatically eliminating large numbers of foods.
- Avoid unproven “kidney detox” products and supplements.
- Attend recommended follow-up testing.
Some people with CKD benefit from kidney-protective medicines such as ACE inhibitors, ARBs, or SGLT2 inhibitors, depending on their diagnosis and individual circumstances. These medications should be used under appropriate medical supervision rather than started, stopped, or adjusted independently.
When Should You Seek Medical Attention?
Seek prompt medical attention for symptoms such as very little or no urine, severe shortness of breath, chest pain, fainting, confusion, severe weakness, significant swelling, or severe vomiting/dehydration.
A sudden major change in creatinine or eGFR also deserves medical evaluation because it may represent AKI rather than ordinary CKD progression.
Bottom Line
Stage 3a CKD = eGFR 45–59 mL/min/1.73 m².
Stage 3b CKD = eGFR 30–44 mL/min/1.73 m².
Stage 3b represents a greater reduction in kidney function and, on average, carries greater risk than Stage 3a. But the stage alone does not tell you how quickly CKD will progress or whether kidney failure will occur.
The most useful picture combines your eGFR trend, urine albumin level, underlying cause, blood pressure, diabetes status, medications, and other health factors. A single eGFR result is only one part of that picture.